Security key
640268108
NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)
CUSIP: 640268108
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 29,109,163
- Total 13F shares
- 137,616,980
- Share change
- -34,861,373
- Total reported value
- $79,156,536
- Put/Call ratio
- 11%
- Price per share
- $0.58
- Number of holders
- 138
- Value change
- -$21,632,445
- Number of buys
- 48
- Number of sells
- 119
Report period
Q2 2023
Institutions
138
Top holders
10
NKTR full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
NEKTAR THERAPEUTICS SEC filings
NEKTAR THERAPEUTICS company facts
Broader feeds
Reporting periods
Holder history for CUSIP 640268108
Recent filing periods:
Top shareholders of NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Invesco Ltd. |
13F
|
Company |
129%
|
37,482,586
|
$26,346,510 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
122%
|
35,558,958
|
$24,994,391 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
68%
|
19,708,437
|
$13,853,060 | — | 31 Mar 2023 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
39%
|
11,483,026
|
$8,071,419 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
24%
|
6,981,089
|
$4,907,007 | — | 31 Mar 2023 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
13%
|
3,720,679
|
$2,615,265 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
12%
|
3,518,076
|
$2,472,855 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
11%
|
3,301,661
|
$2,320,737 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
10%
|
3,003,696
|
$2,111,000 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
9.8%
|
2,863,070
|
$2,012,452 | — | 31 Mar 2023 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
9.4%
|
2,738,029
|
$1,708,530 | — | 31 Mar 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
9%
|
2,618,087
|
$1,840,253 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
8.7%
|
2,544,342
|
$1,788,418 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
7.2%
|
2,084,461
|
$1,464,669 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
7%
|
2,026,450
|
$1,424,392 | — | 31 Mar 2023 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
6.5%
|
1,900,784
|
$1,336,251 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
6.3%
|
1,847,425
|
$1,298,555 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
6.1%
|
1,784,471
|
$1,254,304 | — | 31 Mar 2023 | |
| Deep Track Capital, LP |
13F
|
Company |
6%
|
1,743,248
|
$1,225,329 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
5.5%
|
1,596,210
|
$1,121,976 | — | 31 Mar 2023 | |
| Walleye Capital LLC |
13F
|
Company |
4.4%
|
1,273,379
|
$895,058 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
4.1%
|
1,203,469
|
$845,918 | — | 31 Mar 2023 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
4%
|
1,160,930
|
$816,017 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
3.6%
|
1,052,019
|
$739,464 | — | 31 Mar 2023 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
3.6%
|
1,034,059
|
$726,840 | — | 31 Mar 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
3.4%
|
994,370
|
$698,942 | — | 31 Mar 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
2.3%
|
680,514
|
$478,333 | — | 31 Mar 2023 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
2.3%
|
663,500
|
$466,374 | — | 31 Mar 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
2.2%
|
630,249
|
$442,000 | — | 31 Mar 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
2.1%
|
617,626
|
$434,000 | — | 31 Mar 2023 | |
| Graham Capital Management, L.P. |
13F
|
Company |
2.1%
|
614,897
|
$432,211 | — | 31 Mar 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
1.8%
|
521,707
|
$366,708 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.7%
|
508,137
|
$357,000 | — | 31 Mar 2023 | |
| Edgestream Partners, L.P. |
13F
|
Company |
1.6%
|
477,036
|
$335,309 | — | 31 Mar 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
1.5%
|
448,227
|
$315,059 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
1.5%
|
431,436
|
$303,256 | — | 31 Mar 2023 | |
| Legal & General Group Plc |
13F
|
Company |
1.4%
|
410,332
|
$288,423 | — | 31 Mar 2023 | |
| Swiss National Bank |
13F
|
Company |
1.4%
|
405,700
|
$285,167 | — | 31 Mar 2023 | |
| CM Management, LLC |
13F
|
Company |
1.4%
|
400,000
|
$281,000 | — | 31 Mar 2023 | |
| Inspire Investing, LLC |
13F
|
Company |
1.4%
|
393,749
|
$276,766 | — | 31 Mar 2023 | |
| HRT FINANCIAL LP |
13F
|
Company |
1.3%
|
379,117
|
$266,000 | — | 31 Mar 2023 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
1.1%
|
330,568
|
$232,356 | — | 31 Mar 2023 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.99%
|
288,634
|
$202,880 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.99%
|
287,670
|
$203,000 | — | 31 Mar 2023 | |
| NORGES BANK |
13F
|
Company |
0.9%
|
261,468
|
$183,786 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.88%
|
257,579
|
$180,820 | — | 31 Mar 2023 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.88%
|
256,385
|
$180,000 | — | 31 Mar 2023 | |
| York State Teachers Retirement System New |
13F
|
Individual |
0.87%
|
253,113
|
$178,000 | — | 31 Mar 2023 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.86%
|
251,431
|
$176,731 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.8%
|
232,486
|
$163,000 | — | 31 Mar 2023 |
Institutional Holders of NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) as of Q2 2023
As of 30 Jun 2023,
NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) was held by
138 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
137,616,980 shares.
The largest 10 holders included
Deep Track Capital, LP, VANGUARD GROUP INC, CITADEL ADVISORS LLC, Monaco Asset Management SAM, D. E. Shaw & Co., Inc., BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, Sio Capital Management, LLC, Invesco Ltd., and JACOBS LEVY EQUITY MANAGEMENT, INC.
This page lists
138
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
187
Q2 2023 holders
138
Holder diff
-49
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.